BR0317882A - Processo para fabricação de lipossomas de longa circulação não tratados com peg; lipossoma; composição de doxorrubicina lipossomal de longa duração não tratada com peg; e método - Google Patents

Processo para fabricação de lipossomas de longa circulação não tratados com peg; lipossoma; composição de doxorrubicina lipossomal de longa duração não tratada com peg; e método

Info

Publication number
BR0317882A
BR0317882A BR0317882-0A BR0317882A BR0317882A BR 0317882 A BR0317882 A BR 0317882A BR 0317882 A BR0317882 A BR 0317882A BR 0317882 A BR0317882 A BR 0317882A
Authority
BR
Brazil
Prior art keywords
long
liposome
peg
pegylated
liposomal doxorubicin
Prior art date
Application number
BR0317882-0A
Other languages
English (en)
Inventor
Gautam Vinod Daftary
Srikanth Annappa Pai
Sangeeta Hanurmesh Rivankar
Original Assignee
Bharat Serums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums & Vaccines Ltd filed Critical Bharat Serums & Vaccines Ltd
Publication of BR0317882A publication Critical patent/BR0317882A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes
    • A61K9/1278Post-loading, e.g. by ion or pH gradient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"PROCESSO PARA FABRICAçãO DE LIPOSSOMAS DE LONGA CIRCULAçãO NãO TRATADOS COM PEG; LIPOSSOMA; COMPOSIçãO DE DOXORRUBICINA LIPOSSOMAL DE LONGA DURAçãO NãO TRATADA COM PEG; E MéTODO". A presente invenção proporciona uma composição de doxorrubicina lipossomal não tratada com PEG de longa circulação para administração parenteral e a um processo para a preparação da mesma. O tempo de circulação em camundongos albinos suíços é de pelo menos 25 vezes mais longo do que nas composições não lipossomais convencionais. Os lipossomas não tratados com PEG são estáveis, exibem baixa toxicidade e foi observado ser eficaz nos modelos de diferentes tumores.
BR0317882-0A 2002-12-31 2003-12-31 Processo para fabricação de lipossomas de longa circulação não tratados com peg; lipossoma; composição de doxorrubicina lipossomal de longa duração não tratada com peg; e método BR0317882A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1101MU2002 2002-12-31
PCT/IN2003/000424 WO2004058140A2 (en) 2002-12-31 2003-12-31 Non-pegylated long-circulating liposomes

Publications (1)

Publication Number Publication Date
BR0317882A true BR0317882A (pt) 2005-12-13

Family

ID=32500467

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0317882-0A BR0317882A (pt) 2002-12-31 2003-12-31 Processo para fabricação de lipossomas de longa circulação não tratados com peg; lipossoma; composição de doxorrubicina lipossomal de longa duração não tratada com peg; e método

Country Status (19)

Country Link
EP (1) EP1435231B8 (pt)
JP (1) JP5355842B2 (pt)
KR (2) KR101171045B1 (pt)
CN (1) CN1756533B (pt)
AT (1) ATE453381T1 (pt)
AU (1) AU2003303368B2 (pt)
BR (1) BR0317882A (pt)
CA (1) CA2511464C (pt)
DE (1) DE60330745D1 (pt)
DK (1) DK1435231T3 (pt)
EA (1) EA008930B1 (pt)
ES (1) ES2337563T3 (pt)
HK (1) HK1089946A1 (pt)
IL (1) IL169364A (pt)
MX (1) MXPA05007102A (pt)
NZ (1) NZ540778A (pt)
PT (1) PT1435231E (pt)
WO (1) WO2004058140A2 (pt)
ZA (1) ZA200504850B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2687291A1 (en) * 2007-05-16 2008-11-20 Ktb Tumorforschungsgesellschaft Mbh Low-viscous anthracycline formulation
JP5622719B2 (ja) 2009-03-30 2014-11-12 エーザイ・アール・アンド・ディー・マネジメント株式会社 リポソーム組成物の製造方法
PL2415470T3 (pl) 2009-03-30 2016-12-30 Kompozycja liposomowa
JP2014506922A (ja) * 2011-03-01 2014-03-20 ティーオー − ビービービー ホールディング ベスローテン フェンノートシャップ 難水溶性物質の高度なアクティブリポソームローディング
NZ769187A (en) * 2014-11-25 2023-07-28 Curadigm Sas Pharmaceutical composition, preparation and uses thereof
WO2017188350A1 (ja) 2016-04-28 2017-11-02 エーザイ・アール・アンド・ディー・マネジメント株式会社 腫瘍の成長を抑制する方法
KR20190062485A (ko) * 2016-09-27 2019-06-05 버텍스 파마슈티칼스 인코포레이티드 Dna-손상제 및 dna-pk 저해제의 조합을 사용한 암 치료 방법
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
US12036204B2 (en) 2019-07-26 2024-07-16 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
CN116570775B (zh) * 2023-05-16 2024-08-02 万瑞飞鸿(北京)医疗器材有限公司 一种药物涂层、血管支架及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
WO1985000968A1 (en) * 1983-09-06 1985-03-14 Health Research, Inc. Liposome delivery method for decreasing the toxicity of an antitumor drug
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
CA1270198A (en) * 1984-08-08 1990-06-12 Marcel B. Bally Encapsulation of antineoplastic agents in liposomes
US4920016A (en) 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
JPH0720857B2 (ja) 1988-08-11 1995-03-08 テルモ株式会社 リポソームおよびその製法
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
US6132763A (en) 1988-10-20 2000-10-17 Polymasc Pharmaceuticals Plc Liposomes
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
ES2208946T3 (es) * 1996-08-23 2004-06-16 Sequus Pharmaceuticals, Inc. Liposomas que contienen un compuesto de cisplatino.
ATE238039T1 (de) * 1998-09-16 2003-05-15 Alza Corp In liposomen eingeschlossene topoisomerase inhibitoren
KR20000061075A (ko) * 1999-03-23 2000-10-16 린 중친 리포솜의 응집을 방지하기 위한 방법 및 조성물
GB0111279D0 (en) * 2001-05-10 2001-06-27 Nycomed Imaging As Radiolabelled liposomes

Also Published As

Publication number Publication date
EP1435231B8 (en) 2010-03-03
DE60330745D1 (de) 2010-02-11
DK1435231T3 (da) 2010-04-26
ZA200504850B (en) 2006-08-30
WO2004058140B1 (en) 2004-12-16
NZ540778A (en) 2008-04-30
EP1435231B1 (en) 2009-12-30
MXPA05007102A (es) 2005-08-26
AU2003303368A1 (en) 2004-07-22
KR20110075051A (ko) 2011-07-05
CA2511464C (en) 2011-08-23
WO2004058140A3 (en) 2004-10-28
JP2006513189A (ja) 2006-04-20
CN1756533B (zh) 2010-06-16
IL169364A (en) 2012-05-31
EP1435231A1 (en) 2004-07-07
KR101171045B1 (ko) 2012-08-03
EA200500850A1 (ru) 2006-02-24
AU2003303368B2 (en) 2010-06-17
PT1435231E (pt) 2010-04-08
CN1756533A (zh) 2006-04-05
WO2004058140A2 (en) 2004-07-15
KR101133084B1 (ko) 2012-04-04
KR20050088233A (ko) 2005-09-02
EA008930B1 (ru) 2007-08-31
HK1089946A1 (en) 2006-12-15
JP5355842B2 (ja) 2013-11-27
IL169364A0 (en) 2007-07-04
ATE453381T1 (de) 2010-01-15
CA2511464A1 (en) 2004-07-15
ES2337563T3 (es) 2010-04-27

Similar Documents

Publication Publication Date Title
HK1089946A1 (en) Non-pegylated long-circulating liposomes
AR023055A1 (es) Una formulacion farmaceutica de liposoma mixta con vesiculas multilaminar y un proceso para su preparacion
NO174833C (no) Fremgangsmåte for fremstilling av et injiserbart preparat
HUP9800460A3 (en) Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy or diagnosis, products and kits comprising thereof and method of in vitro diagnosis by their using
ES2081488T3 (es) Uso de fosfolipido en la fabricacion de un medicamento topico para modificar los niveles de colesterol serico.
ATE132742T1 (de) Zusammensetzung und verfahren zur behandlung von zystischer fibrose
ATE203898T1 (de) Verfahren zur herstellung einer liposomen- zubereitung
PT87270A (pt) Processo para a preparacao de 4-de-metoxi-4-amino-antraciclinas
PT89125A (pt) Processo para a preparacao de uma composicao de enxaguamento de tecidos para remocao de residuos de agente tensio-activo, contendo baixos niveis de um agente tensio-activo nao ionico e um acido organico
RU2006141254A (ru) Ингибиторы холинэстеразы в липосомах, а также их получение и применение
IT1283417B1 (it) Procedimento per alimentare una miscela liquida al cilindro mantecatore di una macchina per la produzione di gelato soft e
IT8812585A0 (it) Preparato, in particolare preparato cosmetico antisolare, nonche' metodo per l'introduzione di una sostanza attiva nella pelle
NO913816D0 (no) Fremstilling av liposom- og lipidkompleksblandinger.
DE60110057D1 (de) Liposomen enthaltend eine eingeschlossene verbindung in übersattigter lösung
BR9910916A (pt) Vitamina e de polioxipropilenopolioxietileno, processo para preparar a mesma, tensoativo, antioxidante, e, umectante
BR9606528A (pt) Composto sal de um composto processo para a preparação de um composto composição farmacêutica produto uso de um composto e método para o tratmento de um mamífero que necessita de um agente antineoplásico
AR006345A1 (es) Una composicion farmaceutica para administracion oral que comprende un inhibidor de proteasa del vih y un derivado de tocoferol soluble en agua, y un metodo para preparar dicha composicion.
DK1194109T3 (da) Topiske formuleringer omfattende hud-gennemtrængningsmidler samt anvendelse deraf
CA2241825A1 (en) New monofunctionalized edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
Wertz Liposome dermatics: Chemical aspects of the skin lipid approach
WO1989005636A1 (en) Spontaneous vesiculation of multilamellar liposomes
BR9510250A (pt) Sal de diclavulanato processo para preparar sal de ácido clavulânico e composição farmacêutica
ATE161172T1 (de) Liposomale mittel sowie verfahren zu deren herstellung
ATE112679T1 (de) Wässrige bereitung von liposomenzusammensetzungen.
EP1080719A3 (en) Methods for potentiation of efficacy of topical actives by mono-acyl-(lyso)-glycerophosholipids

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED (IN)

Free format text: TRANSFERIDO DE: BHARAT SERUMS AND VACCINES LIMITED

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement

Owner name: BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED (IN)

Free format text: A FIM DE ATENDER AS DUAS ALTERACOES DE NOME E UMA DE ENDERECO REQUERIDAS ATRAVES DA PETICAO NO 20120116376/RJ, DE 14/12/2012, E NECESSARIO APRESENTAR MAIS UMA GUIA RELATIVA AO TERCEIRO SERVICO SOLICITADO, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2342 DE 24-11-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B25E Requested change of name of applicant rejected

Owner name: BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED (IN)

B25H Request for change of headquarter rejected

Owner name: BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED (IN)